S&P Biotech SPDR (XBI)
85.37 x 100 85.70 x 100
Post-market by (Cboe BZX)
85.53 +0.45 (+0.53%) 03/27/25 [NYSE Arca]
85.37 x 100 85.70 x 100
Post-market 85.44 -0.09 (-0.11%) 19:52 ET
for Thu, Mar 27th, 2025
Results
download Want to compare other data? Select Fields| Symbol | XBI | VHT | IBB | ||
| Company | S&P Biotech SPDR | Healthcare ETF Vanguard | Nasdaq Biotechnology Ishares ETF | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NASDAQ | ||
| Open | 85.34 | 263.55 | 131.19 | ||
| High | 86.18 | 264.90 | 132.46 | ||
| Low | 85.09 | 263.18 | 131.16 | ||
| Last | 85.53 | 264.15 | 131.58 | ||
| Change | +0.45 | +0.48 | +0.44 | ||
| % Change | +0.53% | +0.18% | +0.34% | ||
| Volume | 6,493,500 | 138,600 | 881,600 | ||
| 20-Day Average Volume | 8,137,730 | 176,815 | 1,103,030 | ||
| Previous Close | 85.08 | 263.67 | 131.14 | ||
| Industry | Finance - Investment Funds | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 86.87 | 267.53 | 134.45 | ||
| 20-Day Raw Stochastic | 27.55% | 25.11% | 10.03% | ||
| 20-Day Relative Strength | 43.25% | 45.43% | 42.56% | ||
| Weighted Alpha | -12.51 | -2.85 | -6.31 | ||
| Today's Opinion | 100% Sell | 72% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 72% Sell | 100% Sell | ||
| Last Month's Opinion | 88% Sell | 8% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.22% since 03/20/25 | -1.30% since 03/20/25 | -0.87% since 03/20/25 | ||
| Low | 84.75 on 03/26/25 | 263.09 on 03/26/25 | 130.83 on 03/26/25 | ||
| High | 88.97 on 03/24/25 | 269.86 on 03/24/25 | 135.67 on 03/24/25 | ||
| 1-Month | |||||
| %Chg | -1.80% since 02/27/25 | -1.69% since 02/27/25 | -2.88% since 02/27/25 | ||
| Low | 84.07 on 03/04/25 | 260.94 on 03/13/25 | 130.83 on 03/26/25 | ||
| High | 89.37 on 03/03/25 | 273.72 on 03/03/25 | 138.29 on 03/07/25 | ||
| 3-Month | |||||
| %Chg | -6.37% since 12/27/24 | +3.03% since 12/27/24 | -1.45% since 12/27/24 | ||
| Low | 84.07 on 03/04/25 | 252.13 on 12/30/24 | 130.81 on 01/13/25 | ||
| High | 94.90 on 02/05/25 | 274.19 on 02/05/25 | 142.80 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | -13.11% since 09/27/24 | -5.76% since 09/27/24 | -9.19% since 09/27/24 | ||
| Low | 84.07 on 03/04/25 | 250.07 on 12/19/24 | 129.61 on 12/19/24 | ||
| High | 105.47 on 11/11/24 | 283.73 on 10/14/24 | 150.04 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,560,954 | 16,437,824 | 6,217,155 | ||
| Shares Outstanding, K | 65,375 | 62,349 | 47,250 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 0.97 | 0.73 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.005 on 03/24/25 | 0.940 on 03/25/25 | 0.121 on 03/18/25 | ||
| Next Ex-Dividends Date | 03/24/25 | 03/25/25 | 03/18/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 17.88 | 22.00 | 15.68 | ||